Back to Search

RUTH ORATZ, MD

MD

Medical Oncology Physician

NPI: 1275625592IndividualAccepts Medicare

Specialties, Licenses & Credentials

Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

156851(NY)

CMS Specialties

PrimaryMEDICAL ONCOLOGY

Additional

INTERNAL MEDICINE

Education

ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY

Class of 1982

Research & Publications (10)

Intratumoral cisplatin/adrenaline injectable gel for the treatment of patients with cutaneous and soft tissue metastases of malignant melanoma.
PMID 12569286·Melanoma Res·2003
3-trial
Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.
PMID 19451711·Chemotherapy·2009
3-trial
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.
PMID 19221754·Cancer Chemother Pharmacol·2009
3-trial
Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer.
PMID 17919349·Clin Breast Cancer·2007
3-trial
A comparison of survival rates for treatment of melanoma metastatic to the brain.
PMID 15565805·Cancer Invest·2004
4-observational
Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy.
PMID 11595690·Clin Cancer Res·2001
3-trial
Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine.
PMID 11448900·Clin Cancer Res·2001
3-trial
Decrease in circulating tumor cells as an early marker of therapy effectiveness.
PMID 11092048·Recent Results Cancer Res·2001
8-other
Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis.
PMID 11033019·J Immunol Methods·2000
8-other
Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment.
PMID 11156210·Clin Cancer Res·2000
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
160 E 34TH ST, 4TH FLOOR - NYU PERLMUTTER CANCER CENTER
NEW YORK, NY 10016

Location

Practice Location

160 E 34TH ST, NEW YORK, NY
(212) 731-5760

Quick Facts

NPI
1275625592
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
44
Publications
10

Are you this provider?

Claim Your Profile